SWX:SKANLife Sciences
SKAN Group (SWX:SKAN) Could Be 6% Undervalued On Its Return To Profit
SKAN Group (SWX:SKAN) has drawn fresh attention after reporting H1 2026 net income of CHF 4.81 million, compared with a net loss of CHF 8.9 million a year earlier.
See our latest analysis for SKAN Group.
The swing back to profit in H1 2026 has coincided with a clear shift in sentiment toward SKAN Group, with a 90 day share price return of 26.07% and a year to date gain of 13.03%, even though the 1 year total shareholder return is still down 11.66%.
If SKAN Group’s rebound has you thinking...